These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10831488)

  • 21. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907.
    Ito H; Nyberg S; Halldin C; Lundkvist C; Farde L
    J Nucl Med; 1998 Jan; 39(1):208-14. PubMed ID: 9443763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
    Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
    J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-HT2A receptor density is decreased in the at-risk mental state.
    Hurlemann R; Matusch A; Kuhn KU; Berning J; Elmenhorst D; Winz O; Kolsch H; Zilles K; Wagner M; Maier W; Bauer A
    Psychopharmacology (Berl); 2008 Jan; 195(4):579-90. PubMed ID: 17899021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study.
    Meyer JH; Kapur S; Houle S; DaSilva J; Owczarek B; Brown GM; Wilson AA; Kennedy SH
    Am J Psychiatry; 1999 Jul; 156(7):1029-34. PubMed ID: 10401447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.
    Kapur S; Zipursky R; Remington G; Jones C; McKay G; Houle S
    Am J Psychiatry; 1997 Nov; 154(11):1525-9. PubMed ID: 9356559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET measurement of neuroreceptor occupancy by typical and atypical neuroleptics.
    Goyer PF; Berridge MS; Morris ED; Semple WE; Compton-Toth BA; Schulz SC; Wong DF; Miraldi F; Meltzer HY
    J Nucl Med; 1996 Jul; 37(7):1122-7. PubMed ID: 8965181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased 5-HT2a receptor binding in patients with anorexia nervosa.
    Audenaert K; Van Laere K; Dumont F; Vervaet M; Goethals I; Slegers G; Mertens J; van Heeringen C; Dierckx RA
    J Nucl Med; 2003 Feb; 44(2):163-9. PubMed ID: 12571204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment.
    Hernandez I; Sokolov BP
    J Neurosci Res; 2000 Jan; 59(2):218-25. PubMed ID: 10650880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography.
    Elkashef AM; Doudet D; Bryant T; Cohen RM; Li SH; Wyatt RJ
    Psychiatry Res; 2000 Nov; 100(1):1-11. PubMed ID: 11090720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased serotonin2A receptors in Brodmann's area 9 from schizophrenic subjects. A pathological or pharmacological phenomenon?
    Dean B; Hayes W; Hill C; Copolov D
    Mol Chem Neuropathol; 1998; 34(2-3):133-45. PubMed ID: 10327413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging.
    Kapur S; Jones C; DaSilva J; Wilson A; Houle S
    Nucl Med Commun; 1997 May; 18(5):395-9. PubMed ID: 9194079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients.
    Audenaert K; Van Laere K; Dumont F; Slegers G; Mertens J; van Heeringen C; Dierckx RA
    Eur J Nucl Med; 2001 Feb; 28(2):175-82. PubMed ID: 11303887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia.
    Hurlemann R; Boy C; Meyer PT; Scherk H; Wagner M; Herzog H; Coenen HH; Vogeley K; Falkai P; Zilles K; Maier W; Bauer A
    Anat Embryol (Berl); 2005 Dec; 210(5-6):519-23. PubMed ID: 16187138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin 2A receptors and visual hallucinations in Parkinson disease.
    Ballanger B; Strafella AP; van Eimeren T; Zurowski M; Rusjan PM; Houle S; Fox SH
    Arch Neurol; 2010 Apr; 67(4):416-21. PubMed ID: 20385906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET.
    Meyer JH; Cho R; Kennedy S; Kapur S
    Psychopharmacology (Berl); 1999 Jun; 144(3):279-81. PubMed ID: 10435395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine.
    Attar-Lévy D; Martinot JL; Blin J; Dao-Castellana MH; Crouzel C; Mazoyer B; Poirier MF; Bourdel MC; Aymard N; Syrota A; Féline A
    Biol Psychiatry; 1999 Jan; 45(2):180-6. PubMed ID: 9951565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
    Burnet PW; Eastwood SL; Harrison PJ
    Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
    Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward a brain map of auditory hallucinations.
    Cleghorn JM; Franco S; Szechtman B; Kaplan RD; Szechtman H; Brown GM; Nahmias C; Garnett ES
    Am J Psychiatry; 1992 Aug; 149(8):1062-9. PubMed ID: 1353314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.